Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078886HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30077335HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30019550HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044808HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044809HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044810HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20003334HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20044172HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20066218HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20017200HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB05013
Drug NameIngenol mebutate
Target IDBE0001132
UniProt IDP17252
Regulation Typeligand
PubMed IDs15126366
CitationsKedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM: Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 2004 May 1;64(9):3243-55.
GroupsApproved
Direct ClassificationTigliane and ingenane diterpenoids
SMILES[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C
Pathways
PharmGKB
ChEMBLCHEMBL1863513